Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.
BACKGROUND
The rexinoid bexarotene (LGD1069, Targretin) is a highly selective retinoid x receptor (RXR) agonist that inhibits the growth of pre-malignant and malignant breast cells. Bexarotene was shown to suppress the development of breast cancer in transgenic mice models without side effects. The chemopreventive effects of bexarotene are due to transcriptional modulation of cell proliferation, differentiation and apoptosis. Our goal in the present study was to obtain a profile of the genes modulated by bexarotene on mammary gland from three transgenic mouse mammary cancer models in an effort to elucidate its molecular mechanism of action and for the identification of biomarkers of effectiveness.


METHODS
Serial analysis of gene expression (SAGE) was employed to profile the transcriptome of p53-null, MMTV-ErbB2, and C3(1)-SV40 mammary cells obtained from mice treated with bexarotene and their corresponding controls.


RESULTS
This resulted in a dataset of approximately 360,000 transcript tags representing over 20,000 mRNAs from a total of 6 different SAGE libraries. Analysis of gene expression changes induced by bexarotene in mammary gland revealed that 89 genes were dysregulated among the three transgenic mouse mammary models. From these, 9 genes were common to the three models studied.


CONCLUSIONS
Analysis of the indicated core of transcripts and protein-protein interactions of this commonly modulated genes indicate two functional modules significantly affected by rexinoid bexarotene related to protein biosynthesis and bioenergetics signatures, in addition to the targeting of cancer-causing genes related with cell proliferation, differentiation and apoptosis.
Abba
Martin C
MC
Department of Carcinogenesis, The University of Texas M,D, Anderson Cancer Center, Science Park-Research Division, Smithville, 78957, TX, USA. mabba777@hotmail.com
Hu
Yuhui
Y
Levy
Carla C
CC
Gaddis
Sally
S
Kittrell
Frances S
FS
Zhang
Yun
Y
Hill
Jamal
J
Bissonnette
Reid P
RP
Medina
Daniel
D
Brown
Powel H
PH
Aldaz
C M
CM
J Exp Ther Oncol. 2005;5(2):133-43
16471039
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13892-7
14623968
Breast Cancer Res. 2004;6(5):R499-513
15318932
Genome Biol. 2003;4(5):P3
12734009
Cancer Res. 2001 Aug 1;61(15):5697-702
11479200
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14976-81
12399545
Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):467-74
12010861
Cancer Res. 2000 Nov 1;60(21):5977-83
11085516
J Biol Chem. 2006 Jan 13;281(2):977-81
16263703
Science. 1997 May 23;276(5316):1268-72
9157888
J Biol Chem. 2003 Jul 11;278(28):25752-7
12730199
Cancer Res. 2006 Dec 15;66(24):12009-18
17178900
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10578-82
1359541
Biochem J. 2004 Feb 15;378(Pt 1):17-20
14683524
Cancer Res. 1999 Nov 1;59(21):5464-70
10554019
Cancer Res. 2002 Nov 15;62(22):6376-80
12438218
Nat Rev Cancer. 2006 Jul;6(7):493-505
16794633
Breast Cancer Res. 2005;7(5):R737-44
16168119
Cancer Res. 2005 Aug 15;65(16):7378-85
16103090
Nat Cell Biol. 2001 Apr;3(4):E95-8
11283628
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D433-7
15608232
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):511-6
9892664
Cancer Res. 2004 Nov 1;64(21):7748-55
15520179
Int J Cancer. 2000 Nov 1;88(3):392-400
11054668
J Biol Chem. 2000 Mar 10;275(10):7087-94
10702275
Mutat Res. 2005 Aug 25;576(1-2):93-110
15888345
Mol Cell Biochem. 1999 Sep;199(1-2):41-8
10544950
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5992-7
15840712
Br J Cancer. 1998 Sep;78(6):701-9
9743287
Oncogene. 2000 Feb 21;19(8):1052-8
10713689
Oncogene. 2002 Sep 12;21(41):6366-76
12214277
Genome Res. 1997 Oct;7(10):986-95
9331369
Eur J Cancer Clin Oncol. 1989 Feb;25(2):243-50
2702979
EMBO J. 1998 May 1;17(9):2526-33
9564035
Biochem Biophys Res Commun. 1999 Apr 21;257(3):865-70
10208875
Cancer Res. 2001 Nov 1;61(21):7878-81
11691807
BMC Cancer. 2006 Jul 12;6:186
16836752
J Steroid Biochem Mol Biol. 1998 Dec;67(5-6):391-402
10030688
Clin Cancer Res. 2004 Jul 1;10(13):4427-36
15240533
Genome Biol. 2003;4(10):R70
14519205
Leukemia. 1994 Nov;8(11):1797-806
7967725
Bioinformatics. 2003 Nov 1;19(16):2065-71
14594711
Biochem J. 2003 Feb 15;370(Pt 1):195-203
12429024
Cancer Biol Ther. 2005 Sep;4(9):918-23
16103750
Carcinogenesis. 2005 Dec;26(12):2095-104
16033770
Nucleic Acids Res. 2007 Jan;35(Database issue):D358-62
17098935
Int J Cancer. 1999 Jun 11;81(6):923-9
10362140
Oncogene. 2000 Feb 21;19(8):1020-7
10713685
J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):1-12
12757018
CA Cancer J Clin. 2006 May-Jun;56(3):168-83
16737949
Science. 1956 Feb 24;123(3191):309-14
13298683
Clin Cancer Res. 2003 Jul;9(7):2567-75
12855632